Utama › Kanser Rektum › Massachusetts
Kajian klinikal Kanser Rektum di Massachusetts
15 kajian untuk Kanser Rektum sedang mencari peserta di lokasi di Massachusetts.
Bandar di Massachusetts
Teks kajian rasmi (Bahasa Inggeris)
Distance-Based Exercise to Preserve Function and Prevent Disability
- Dana-Farber Cancer Institute, Boston
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07059884The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial
- Dana-Farber Cancer Institute, Boston
- Brigham and Women's Hospital, Boston
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06565052Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Dana Farber Cancer Institute, Boston
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06128551A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- Massachusetts General Hospital - Main Campus, Boston
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07629960Resilience and Equity in Aging, Cancer, and Health (REACH)
- Dana-Farber Cancer Institute, Boston
Mengambil peserta
Umur 65 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT04674267Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Massachusetts General Hospital Cancer Center, Boston
- Boston Veteran's Affairs Medical Center, Jamaica Plain
Mengambil peserta
Umur 45 hingga 70 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT05080673Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
- Massachusetts General Hospital, Boston
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT07351071RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07735624Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
- Beverly Hospital, Beverly
- Lahey Clinic, Burlington
- Addison Gilbert Hospital, Gloucester
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Jul 2026 · NCT06205485A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Mass General Brigham Cancer Institute at Massachusetts General Hospital, Boston
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jun 2026 · NCT07458347Integrated Cancer Repository for Cancer Research
- Holyoke Medical Center, Holyoke
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 19 hingga 110 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT02012699Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Massachusetts General Hospital, Boston
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT06239194Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- Dana Farber Cancer Institute, Boston
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Feb 2026 · NCT03516708SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Worcester
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Mei 2025 · NCT05914766Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.